MELK and metastatic malignant neoplasm in the lymph nodes: Subsequently, we observed we that OSCC with lymph node metastasis had a stronger immunoreactivity than OSCC without lymph node metastasis, and the expression of MELK was higher in metastatic lymph nodes than in the original tumour.